IL-10 Receptor Function in Lung Inflammation
IL-10 受体在肺部炎症中的功能
基本信息
- 批准号:6528167
- 负责人:
- 金额:$ 32.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Efficient regulation of inflammation in the lungs is essential not only to
allow for rapid mobilization of inflammatory cells during infection, but also
to prevent inflammation during exposure of the lungs to innocuous substances.
Normal homeostatic conditions in the lungs are generally thought to be
immunosuppressive, due in part to alveolar macrophages (AM) which can release
inhibitory factors including nitric oxide, prostaglandins, transforming growth
factor and interleukin-10 (IL-10). Binding of IL-10 to IL-10 receptors on AM
dramatically inhibits the production of proinflammatory cytokines, IL-1, IL-6,
IL-8 and TNFalpha. However, we have shown that under inflammatory conditions,
AM become hyporesponsive to IL-10 in that synthesis of TNFalpha and IL-6
cannot be effectively inhibited by IL-10. Bronchoalveolar epithelial cells
(EpC) also have been shown to constitutively release IL-10, but to loose that
capacity during inflammatory conditions. We hypothesize that under normal
conditions in the lung, an inhibitory loop is active in which constitutively
produced IL-10 by EpC acts on AM to prevent inappropriate synthesis of
proinflammatory cytokines. Following exposure to infectious microorganisms,
the homeostatic production of IL-10 by EpC and/or the response of the IL-10
receptors on AM are rapidly diminished via signaling through pattern
recognition receptors on EpC and AM. Induction of proinflammatory cytokines in
the lungs is thus more efficiently induced by microbial rather than by non-microbial
substances. Using in vivo murine models and cell culture models, we
will evaluate the following: 1.) What changes are induced in the synthesis
of IL-10 by alveolar epithelial cells and in IL-10 receptor function on
alveolar macrophages by microbial and non-microbial stimuli? 2.) Is
induction of IL-10 hyporesponsiveness in alveolar macrophages mediated via
pattern recognition receptors, including Toll-like receptors and phagocytic
receptors? 3.) Is IL-10 receptor hyporesponsiveness mediated directly via
inhibition of signal transduction pathways or indirectly via synthesis of
inhibitory molecules such as "suppressors of cytokine signaling" (SOCS)? 4.)
Can IL-10 hyporesponsiveness in vivo be ameliorated by inhibition of Toll-like
receptor signaling?
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD A COHEN其他文献
DONALD A COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD A COHEN', 18)}}的其他基金
Modulation of colitis-associated cancer by cyclosporine A
环孢菌素 A 对结肠炎相关癌症的调节
- 批准号:
8636275 - 财政年份:2014
- 资助金额:
$ 32.58万 - 项目类别:
Modulation of colitis-associated cancer by cyclosporine A
环孢菌素 A 对结肠炎相关癌症的调节
- 批准号:
8787456 - 财政年份:2014
- 资助金额:
$ 32.58万 - 项目类别:
Flow Cytometry and Cell Sorting Shared Resource Facility
流式细胞术和细胞分选共享资源设施
- 批准号:
10470107 - 财政年份:2013
- 资助金额:
$ 32.58万 - 项目类别:
Flow Cytometry and Cell Sorting Shared Resource Facility
流式细胞术和细胞分选共享资源设施
- 批准号:
10204888 - 财政年份:2013
- 资助金额:
$ 32.58万 - 项目类别:
Cell Sorter Upgrade for Flow Cytometry Service Facility
流式细胞术服务设施的细胞分选机升级
- 批准号:
8052309 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
IL-10 Receptor Function in Lung Inflammation
IL-10 受体在肺部炎症中的功能
- 批准号:
6784577 - 财政年份:2001
- 资助金额:
$ 32.58万 - 项目类别:
IL-10 Receptor Function in Lung Inflammation
IL-10 受体在肺部炎症中的功能
- 批准号:
6610965 - 财政年份:2001
- 资助金额:
$ 32.58万 - 项目类别:
IL-10 Receptor Function in Lung Inflammation
IL-10 受体在肺部炎症中的功能
- 批准号:
6442691 - 财政年份:2001
- 资助金额:
$ 32.58万 - 项目类别:
INTERSTITIAL PNEUMONIA AFTER BONE MARROW TRANSPLANTATION
骨髓移植后的间质性肺炎
- 批准号:
2702366 - 财政年份:1999
- 资助金额:
$ 32.58万 - 项目类别:
相似海外基金
How do cytokine receptors transmit signals?
细胞因子受体如何传递信号?
- 批准号:
DP230102422 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2022
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Grants Program - Individual
Deciphering novel cross-talk between innate cytokine receptors
破译先天细胞因子受体之间的新型串扰
- 批准号:
DP210103122 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Grants Program - Individual
A dissection of transmembrane signal transduction and downstream signaling response in cytokine receptors
细胞因子受体跨膜信号转导和下游信号反应的剖析
- 批准号:
412345 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Fellowship Programs
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
- 批准号:
RGPIN-2018-04852 - 财政年份:2018
- 资助金额:
$ 32.58万 - 项目类别:
Discovery Grants Program - Individual
Development of analysis method of inflammation-related proteins in serum using inflammatory cytokine receptors
开发利用炎症细胞因子受体分析血清中炎症相关蛋白的方法
- 批准号:
17K18360 - 财政年份:2017
- 资助金额:
$ 32.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Mutations and single nucleotide polymorphisms of cytokine receptors in Kawasaki disease
川崎病细胞因子受体突变及单核苷酸多态性
- 批准号:
16K10020 - 财政年份:2016
- 资助金额:
$ 32.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)